KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Assets (2016 - 2026)

Medpace Holdings filings provide 12 years of Current Assets readings, the most recent being $1.1 billion for Q1 2026.

  • On a quarterly basis, Current Assets rose 38.67% to $1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 38.67% increase, with the full-year FY2025 number at $989.6 million, down 3.85% from a year prior.
  • Current Assets hit $1.1 billion in Q1 2026 for Medpace Holdings, up from $989.6 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.1 billion in Q1 2026 to a low of $328.9 million in Q2 2022.
  • Median Current Assets over the past 5 years was $593.8 million (2023), compared with a mean of $649.0 million.
  • Biggest five-year swings in Current Assets: tumbled 51.66% in 2022 and later skyrocketed 130.26% in 2024.
  • Medpace Holdings' Current Assets stood at $334.0 million in 2022, then soared by 77.81% to $593.8 million in 2023, then surged by 73.32% to $1.0 billion in 2024, then decreased by 3.85% to $989.6 million in 2025, then increased by 15.1% to $1.1 billion in 2026.
  • The last three reported values for Current Assets were $1.1 billion (Q1 2026), $989.6 million (Q4 2025), and $737.3 million (Q3 2025) per Business Quant data.